17 insiders reported 83 Form 4 transactions for Emergent BioSolutions Inc. (EBS) over the past 18 months (most recent 2026-07-02). Recent activity: Williams Paul Anthony (SVP, Products Business) Sell 3,000 shares, LINDAHL RICHARD S (EVP, Chief Financial Officer) Sell 3,964 shares, Glessner Coleen (EVP, Quality & Ethics, and CPL) Sell 2,018 shares, Williams Paul Anthony (SVP, Products Business) Sell 694 shares, Hartzel William (SVP, Bioservices) Sell 1,741 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Williams Paul Anthony | SVP, Products Business | Sell | 3,000 | $25,200 |
| 2026-06-10 | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 3,964 | $31,712 |
| 2026-06-10 | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 2,018 | $16,144 |
| 2026-06-10 | Williams Paul Anthony | SVP, Products Business | Sell | 694 | $5,552 |
| 2026-06-10 | Hartzel William | SVP, Bioservices | Sell | 1,741 | $13,928 |
| 2026-05-01 | LINDAHL RICHARD S | EVP, Chief Financial Officer | Buy | 162,680 | $0 |
| 2026-05-01 | PAPA JOSEPH C | President and CEO | Buy | 187,708 | $0 |
| 2026-05-01 | Glessner Coleen | EVP, Quality & Ethics, and CPL | Buy | 100,111 | $0 |
| 2026-05-01 | Williams Paul Anthony | SVP, Products Business | Buy | 100,111 | $0 |
| 2026-05-01 | Hartzel William | SVP, Bioservices | Buy | 100,111 | $0 |
| 2026-05-01 | Perl Jessica | SVP, General Counsel, Corp Sec | Buy | 104,282 | $0 |
| 2026-05-01 | Lowry Simon C | SVP, R&D, CMO | Buy | 100,111 | $0 |
| 2026-04-03 | Williams Paul Anthony | SVP, Products Business | Sell | 4,000 | $33,760 |
| 2026-03-05 | Lowry Simon C | SVP, R&D, CMO | Sell | 10,636 | $89,768 |
| 2026-03-05 | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 23,650 | $199,606 |
| 2026-03-05 | PAPA JOSEPH C | President and CEO | Sell | 37,055 | $312,744 |
| 2026-03-05 | Perl Jessica | SVP, General Counsel, Corp Sec | Sell | 6,465 | $54,565 |
| 2026-03-05 | Williams Paul Anthony | SVP, Products Business | Sell | 9,397 | $79,311 |
| 2026-03-05 | Hartzel William | SVP, Bioservices | Sell | 9,493 | $80,121 |
| 2026-03-05 | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 8,199 | $69,200 |
| 2026-03-05 | FOWLER JOHN D JR | Director | Buy | 5,006 | $45,004 |
| 2026-03-03 | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 683 | $5,566 |
| 2026-03-03 | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 313 | $2,551 |
| 2026-03-03 | Williams Paul Anthony | SVP, Products Business | Sell | 116 | $945 |
| 2026-02-10 | Hartzel William | SVP, Bioservices | Sell | 5,771 | $63,019 |
Source: SEC Form 4 filings · as of 2026-07-02